Clinical Trial

Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2025 (before its estimated September 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury
Trial Details
NCT Number NCT06870370
Lead Sponsor Tanta University
Conditions Traumatic Brain Injury (TBI) Patients, Intracranial Pressure, Intensive Care Unit, Mortality
Enrollment 60 participants
Start Date 2025-09-20
Primary Completion 2025-09-20 (estimated)
Study Completion 2025-09-20 (estimated)
Updated on ClinicalTrials.gov 2025-03-11